MARKET

RMTI

RMTI

Rockwell Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.120
+0.110
+5.47%
After Hours: 2.170 +0.05 +2.36% 16:15 04/08 EDT
OPEN
2.040
PREV CLOSE
2.010
HIGH
2.215
LOW
1.990
VOLUME
747.76K
TURNOVER
--
52 WEEK HIGH
5.80
52 WEEK LOW
1.306
MARKET CAP
146.38M
P/E (TTM)
-3.7509
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RMTI stock price target is 8.67 with a high estimate of 11.00 and a low estimate of 6.00.

EPS

RMTI News

More
  • Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors
  • GlobeNewswire · 03/31 21:30
  • Rockwell Medical Appoints Robert S. Radie to Board of Directors
  • Benzinga · 03/31 20:35
  • Bristol-Myers' Ozanimod Approval, And Other News: The Good, Bad And Ugly Of Biopharma
  • Seeking Alpha - Article · 03/30 09:39
  • Rockwell Medical, Inc. Receives FDA Approval for Triferic® AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients
  • GlobeNewswire · 03/27 16:21

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company. The Company is targeting end-stage renal disease and chronic kidney disease with products for the treatment of iron deficiency and hemodialysis. The Company is also a manufacturer of hemodialysis concentrates for dialysis providers and distributors. The Company’s renal drug therapy, Triferic, supports disease management initiatives. Triferic is therapy indicated to replace iron and maintain hemoglobin in hemodialysis patients via dialysate during each dialysis treatment. The Company has developed multiple formulations of Triferic: Dialysate Triferic and Intravenous Triferic (I.V. Triferic). Dialysate Triferic is the therapeutic indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients.
More

Webull offers kinds of Rockwell Medical Inc stock information, including NASDAQ:RMTI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMTI stock news, and many more online research tools to help you make informed decisions.